Natus wins three-year Novation contract for neoBLUE:
This article was originally published in Clinica
Executive Summary
Natus Medical, the San Carlos, California company specialising in medical devices for the paediatric market, has secured a three-year agreement to supply Novation with its neoBLUE LED phototherapy systems, used to treat neonatal jaundice. Irving, Texas-based Novation, in turn, will distribute the devices to US healthcare alliances VHA and University HealthSystem Consortium. The neoBLUE system uses a therapeutic blue LED (light emitting diode) light to degenerate excess bilirubin in jaundiced infants. Healthcare users have said the product provides effective and safe treatment to babies over a shorter period of time, the company claims.
You may also be interested in...
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.